Triple

T19992750
Position Surface form Disambiguated ID Type / Status
Subject Exelon Patch E494103 entity
Predicate regulatesEnzyme P51774 FINISHED
Object butyrylcholinesterase — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: butyrylcholinesterase | Statement: [Exelon Patch, regulatesEnzyme, butyrylcholinesterase]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: butyrylcholinesterase
Context triple: [Exelon Patch, regulatesEnzyme, butyrylcholinesterase]
  • A. catechol-O-methyltransferase
    Catechol-O-methyltransferase is an enzyme that inactivates catecholamine neurotransmitters and related drugs by transferring a methyl group to their catechol structures.
  • B. ase
    "ase" is the ISO 639-3 language code assigned to American Sign Language, the primary sign language used by Deaf communities in the United States and parts of Canada.
  • C. Activase
    Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
  • D. Chelechol
    Chelechol is a small village located within Aimeliik State in the island nation of Palau.
  • E. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: butyrylcholinesterase
Target entity description: Butyrylcholinesterase is a human enzyme that hydrolyzes choline-based esters and plays a role in drug metabolism and modulation of cholinergic neurotransmission.
  • A. catechol-O-methyltransferase
    Catechol-O-methyltransferase is an enzyme that inactivates catecholamine neurotransmitters and related drugs by transferring a methyl group to their catechol structures.
  • B. ase
    "ase" is the ISO 639-3 language code assigned to American Sign Language, the primary sign language used by Deaf communities in the United States and parts of Canada.
  • C. Activase
    Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
  • D. Chelechol
    Chelechol is a small village located within Aimeliik State in the island nation of Palau.
  • E. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69da626a67648190af9653832a3aeced completed April 11, 2026, 3:02 p.m.
NER Named-entity recognition batch_69e65fe10ffc81908c94168b0a8ea9c9 completed April 20, 2026, 5:18 p.m.
Created at: April 11, 2026, 3:31 p.m.